Remington-Davis
Remington-Davis is a leading clinical research site and trial management partner based in Columbus, Ohio, with over 30 years of experience. They focus on providing high-quality clinical trial management, patient recruitment, and data integrity services across various therapeutic areas, including dermatology, COPD, cardiovascular, nephrology, and rare diseases. Their mission is to support healthcare advancements through efficient, patient-centric clinical trials, fostering diversity, innovation, and regulatory compliance.
Industries
Nr. of Employees
small (1-50)
Remington-Davis
Services
Full-service on-site operations including participant visits, complex procedures, infusion and PK sampling, ECGs, pulmonary function testing, and long-duration visit management.
Multichannel recruitment campaigns, prescreening from an internal volunteer registry, IRB-approved digital advertising, community outreach, and a 24-hour hotline to accelerate enrollment.
Feasibility assessments, rapid contract and IRB workflows, and consultative site selection to optimize enrollment and timelines.
Support for IRB submissions, ICH-GCP adherence, 21 CFR Part 11 readiness, system validation, vendor management, and regulatory documentation management.
EDC entry, eSource implementation and integration, CTMS use, remote monitoring facilitation, and near real-time data visibility for sponsors.
Operational support for virtual visits, telemedicine platforms, decentralized workflows, and participant-centric logistics such as transportation and flexible scheduling.
Full-service on-site operations including participant visits, complex procedures, infusion and PK sampling, ECGs, pulmonary function testing, and long-duration visit management.
Multichannel recruitment campaigns, prescreening from an internal volunteer registry, IRB-approved digital advertising, community outreach, and a 24-hour hotline to accelerate enrollment.
Feasibility assessments, rapid contract and IRB workflows, and consultative site selection to optimize enrollment and timelines.
Support for IRB submissions, ICH-GCP adherence, 21 CFR Part 11 readiness, system validation, vendor management, and regulatory documentation management.
EDC entry, eSource implementation and integration, CTMS use, remote monitoring facilitation, and near real-time data visibility for sponsors.
Operational support for virtual visits, telemedicine platforms, decentralized workflows, and participant-centric logistics such as transportation and flexible scheduling.
Expertise Areas
- Clinical trial management (Phase I–IV)
- Participant recruitment and retention strategies
- Decentralized and hybrid trial operations
- Regulatory compliance (21 CFR Part 11, HIPAA, ICH-GCP)
Key Technologies
- Clinical Trial Management System (CTMS)
- Electronic Data Capture (EDC)
- eSource implementation
- Electronic Trial Master File / eRegulatory (eTMF)
News & Updates
Guidelines on maintaining secure, computer-generated audit trails to support data integrity and regulatory compliance in clinical trials.
Exploring how artificial intelligence can support faster patient recruitment, retention, and data analysis to reduce costs and delays in clinical research.
Announcement of a new space in Columbus, Ohio, dedicated to COVID-19 clinical trials, including private rooms, labs, and patient amenities.
Strategies for engaging diverse communities through events, wellness clinics, partnerships, and digital outreach to promote inclusivity.
Discussion on the increasing focus on rare diseases in clinical research, with insights into challenges and opportunities for sites.
The role of electronic patient-reported outcomes (ePRO) systems in enhancing data quality and patient involvement in trials.
Guidelines on maintaining secure, computer-generated audit trails to support data integrity and regulatory compliance in clinical trials.
Exploring how artificial intelligence can support faster patient recruitment, retention, and data analysis to reduce costs and delays in clinical research.
Announcement of a new space in Columbus, Ohio, dedicated to COVID-19 clinical trials, including private rooms, labs, and patient amenities.
Strategies for engaging diverse communities through events, wellness clinics, partnerships, and digital outreach to promote inclusivity.
Discussion on the increasing focus on rare diseases in clinical research, with insights into challenges and opportunities for sites.
The role of electronic patient-reported outcomes (ePRO) systems in enhancing data quality and patient involvement in trials.